Cargando…
Delivery of Orally Administered Digestible Antibodies Using Nanoparticles
Oral administration of medications is highly preferred in healthcare owing to its simplicity and convenience; however, problems of drug membrane permeability can arise with any administration method in drug discovery and development. In particular, commonly used monoclonal antibody (mAb) drugs are d...
Autor principal: | Tashima, Toshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036930/ https://www.ncbi.nlm.nih.gov/pubmed/33805888 http://dx.doi.org/10.3390/ijms22073349 |
Ejemplares similares
-
Delivery of Intravenously Administered Antibodies Targeting Alzheimer’s Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis
por: Tashima, Toshihiko
Publicado: (2022) -
The influence of lipid digestion on the fate of orally administered drug delivery vehicles
por: Boyd, Ben J., et al.
Publicado: (2021) -
Delivery of Drugs into Cancer Cells Using Antibody–Drug Conjugates Based on Receptor-Mediated Endocytosis and the Enhanced Permeability and Retention Effect
por: Tashima, Toshihiko
Publicado: (2022) -
Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody Conjugates
por: Tashima, Toshihiko
Publicado: (2022) -
Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin
por: Tashima, Toshihiko
Publicado: (2020)